MedTrace Logo

Prospective Multicenter Study for the Endovascular Treatment of Iliac Aneurysm With the Branched E-liac Stent Graft

NCT02692664 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 71

Last updated 2026-02-17

No results posted yet for this study

Summary

In this study, patients will be observed who receive an E-liac Stent Graft for treatment of isolated iliac aneurysms or an E-liac Stent Graft in combination with one of the following AAA stent grafts: E-tegra Stent Graft, Endurant AAA Stent Graft, Zenith AAA Endovascular Graft, Gore Excluder AAA Endoprosthesis for treatment of aorto-iliac aneurysms.

Objectives of this post-market registry are:

Primary: To prevent the risk of rupture and death by the treatment of common iliac aneurysm with an iliac branched stent graft (E-liac, JOTEC) Secondary: Evaluation of safety and feasibility of the E-liac Stent Graft System used in endovascular treatment of uni- or bilateral aorto-iliac or iliac aneurysm.

Conditions

  • Iliac Aneurysm
  • AAA

Interventions

DEVICE

Endovascular aorto-iliac repair

Sponsors & Collaborators

  • JOTEC GmbH

    lead INDUSTRY

Principal Investigators

  • Adrien Kaladji, Prof. · CHU Rennes

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-05-01
Primary Completion
2024-07-05
Completion
2024-07-05

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02692664 on ClinicalTrials.gov